Table 2.
Pharmacological actions/domains
| Medicines | Pharmacological actions/domains | Abbreviations |
|---|---|---|
| Oxytocin | Hypothalamic hormone | HPH |
| Haloperidol | First-generation antipsychotic | FGA |
| Lurasidone | Serotonin–dopamine antagonist | SDA |
| Paliperidone | Serotonin–dopamine antagonist | SDA |
| Ziprasidone | Serotonin–dopamine antagonist | SDA |
| Risperidone | Serotonin–dopamine antagonist | SDA |
| Quetiapine | Multi-acting receptor-targeted antipsychotic | MARTA |
| Olanzapine | Multi-acting receptor-targeted antipsychotic | MARTA |
| Aripiprazole | Dopamine system stabilizer | DSS |
| Raloxifene | Sex hormone modulator | SH |
| Pregnenolone | Sex hormone modulator | SH |
| Armodafinil | Stimulant | STIM |
| Modafinil | Stimulant | STIM |
| D-Cycloserine | Antibiotic | ATB |
| Minocycline | Antibiotic | ATB |
| Donepezil | Cholinesterase inhibitor | ChEI |
| Galantamine | Cholinesterase inhibitor | ChEI |
| Nicotine | Nicotine | Nicotine |
| TC-5619 | Alpha-7 nicotinic receptor agonist | Nicotine |
| Valacyclovir | Antiviral drug | AVD |
| Tocilizumab | Immunosuppressive drug | ISD |
| N-Acetylcysteine | Antioxidant | AO |
| Valproate | Anticonvulsant | AC |
| GSK239512 | Histamine H3 receptor antagonist (Antihistamine) | AH |
| Biperiden | Anti- Parkinson | APa |
| Amphetamine | Amphetamine | AMP |
| Cannabidiol | Cannabis | Cannabis |
| BI 409306 | Phosphodiesterase 9 inhibitor | PDEI |
| BI 425809 | Glycine Transporter inhibitor | GlyTI |
| Org 25935 | Selective glycine uptake inhibitor | GlyUI |
| MK-0777 | γ-Aminobutyric acid (A) α2/α3 partial agonist | GABA |
| Memantine | N-Methyl-D-aspartate antagonist | NMDA_ANTAG |
| L-Tetrahydropalmatine | Alkaloid | Alkaloid |
| Curcumin | Polyphenol | PPh |
| Pravastatin | Statin | STAT |
| Placebo | Placebo | PLBO |